Skip to main content
. 2015 Mar 16;6(5):562–567. doi: 10.1021/acsmedchemlett.5b00050

Table 2. In Vivo Rat PK Properties after Dosing of 3 mg/kg IV and 10 mg/kg PO.

rat PKa 15b 16b 17c
CL (mL/min/kg) 56.9 45.5 45.2
Vss (L/kg) 2.3 2.4 4.9
T1/2 (h) 0.83 0.9 1.6
AUC PO (h·nM) 659 1897 1879
Cmax PO (nM) 110 250 215
F(%) PO 10 26 27
a

Route: Intravenous (3 mg/kg) and oral administrations (10 mg/kg). Formulation as a solution in 75% PEG300/25% D5W.

b

Male Sprague–Dawley rat.

c

Male Wistar rat.